#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus infection Infantile apnoea Granulomatosis with polyangiitis Congenital nephrogenic diabetes insipidus Usher's syndrome Stiff person syndrome Candida infection Ewing's sarcoma Pseudoxanthoma elasticum Skin cancer Gastrooesophageal cancer Prodromal Alzheimer's disease Pulmonary alveolar haemorrhage Autologous haematopoietic stem cell transplant Growth hormone deficiency More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Trials in Disease Lymphatic malformation Rhabdomyosarcoma Erdheim-Chester disease – Basic Information Rosai-Dorfman syndrome – Diagnostics Systemic sclerosis pulmonary Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Myelodysplastic syndrome – Diagnostics Lymphangioma – Treatment Mucous membrane pemphigoid – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Milnacipran Hydrochloride Pemetrexed Diacid Monohydrate Capmatinib Alprazolam Eight Treg Bepirovirsen L-Tryptophan ANOC-001 Acenocoumarol Fosamprenavir Calcium Ulotaront AMMONIUM (15N) CHLORIDE Plitidepsin Ciclosporin JX10 Nifedipine Dapagliflozin Propanediol Cefiderocol Brigatinib Risankizumab More therapies…

    Learn about Your Condition

    Hydrocephalus Streptococcal infection Urinary tract infection Metastases to lymph nodes Tumour of ampulla of Vater Wolfram syndrome Anogenital warts Peritonitis Oedema peripheral Respiratory failure Biliary neoplasm Laparoscopic surgery Pulmonary congestion Thyroid mass Oropharyngeal cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of OSU6162 in Adults with Bipolar Depression to Evaluate Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • 3-(3-Methanesulfonyl-Phenyl)-1-Propyl-Piperidine Hydrochloride
    Sweden

  • Study on Preventing Opioid-Induced Constipation in Advanced Cancer Patients Using Magnesium Hydroxide and Macrogol 3350 Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Magnesium Hydroxide
    • Macrogol 3350
    • Potassium Chloride
    The Netherlands

  • Evaluation of Two Prednisolone Treatment Strategies for Newly Diagnosed, Untreated Rheumatoid Arthritis Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Prednisolone
    Sweden

  • Study on Anakinra for Patients with Intracerebral Hemorrhage to Reduce Brain Swelling After Stroke

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Anakinra
    The Netherlands

  • Study of MEN1703 and Glofitamab for Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • B-cell lymphoma recurrent
    • B-cell lymphoma refractory
    Investigated Drugs:
    • 5,6-Dibromo-4-Nitro-2-Piperidin-4-Yl-1-Propan-2-Ylbenzimidazole
    • Glofitamab
    • Obinutuzumab
    France Poland Spain

  • Study of hydroxychloroquine with low-dose corticosteroids compared to medium-dose corticosteroids in patients with pulmonary sarcoidosis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    • Prednisolone
    • Prednisone
    France
Previous Page
1 … 630 631 632 633 634 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!